Citations

Showing 10 of 108081 citations.

Pilot report: non-operative treatment of Mayo Type II olecranon fractures in any-age adult patient
Putnam, Matthew D. , Christophersen, Christy, Adams, Julie E. , Adams, Julie , Adams, Julie E

Mayo Clinic

Shoulder & Elbow | June 6, 2017 | Volume: 9 | Issue: 4 | Pages: 285-291

10.1177/1758573217711889 | PMID 28932286 Get It

Background We report on the non-operative treatment of Mayo Type II olecranon fractures. Methods Fourteen isolated Mayo Type II olecranon fractures were treated non-operatively, followed to discharge, and retrospectively reviewed. Treatment was splinting in extension followed by protected active motion beginning 3 weeks to 4 weeks post-injury. Mayo Elbow Performance Index (MEPI) and Shortened Disabilities of the Arm, Shoulder and Hand (QuickDASH) scores were available in 86% and 64% of cases, respectively. Follow-up radiographs were obtained. Results At discharge, the mean (SD) MEPI score was 95 (5). The mean (SD) elbow motion arc was 121° (21°). One patient re-fractured his elbow after discharge by falling on the ice. He recovered after open reduction and internal fixation. One patient (documented Marfan syndrome) developed an asymptomatic non-union. Excepting the patient who fell, no patient received additional care. Conclusions In this pilot report, Mayo Type II olecranon fractures were treated non-operatively to discharge. Good to excellent results were obtained in all patients according to the MEPI. Supportive care of these fractures should be comparatively studied. A downside risk to providing supportive care for these fractures was not identified.
Comparison of Levetiracetam Dosing Regimens in End-Stage Renal Disease Patients Undergoing Intermittent Hemodialysis
Shiue, Harn , Taylor, Maria E., Sands, Kara, Shiue, Harn J, Sands, Kara A, Shiue, Harn J

Mayo Clinic

Annals of Pharmacotherapy | June 6, 2017 | Volume: 51 | Issue: 10 | Pages: 862-865

10.1177/1060028017713294 | PMID 28582998 Get It

Background: Levetiracetam (LEV) is primarily renally eliminated. In end-stage renal disease (ESRD) patients on hemodialysis (HD), pharmacokinetic studies recommend daily dosing with 50% supplemental doses after 4-hour HD sessions. However, poor medication adherence after HD could result in fluctuating plasma drug levels. Objective: To compare two LEV dosing regimens, daily versus twice-daily (BID), in ESRD patients undergoing HD. Methods: Consecutive ESRD patients (April 2013 to May 2014) receiving maintenance inpatient HD and prescribed LEV prior to admission to our academic tertiary hospital were prospectively analyzed. Demographics, initial lab values, adverse reactions, seizures, and LEV regimens were recorded. LEV levels were obtained pre-HD and post-HD along with levels after receiving post-HD doses. Recovery of plasma levels after HD was assessed by comparison of levels predialysis versus postdialysis and post-HD doses. Results: We identified 22 patients who met inclusion criteria; 14 BID and 8 daily dosing. Mean predialysis, postdialysis, and post-HD dose plasma levels were higher in patients receiving LEV BID compared with daily (43.1 ± 6.3, 19.4 ± 5.2, 34.9 ± 4.3 vs 21.1 ± 3.9, 6.9 ± 1.5, 11.9 ± 1.7 µg/mL; P < 0.05). BID post-HD levels were 41.9 ± 4.6% of predialysis levels versus 36.9 ± 7.3% with daily dosing ( P = 0.275). Post-HD dose levels were 81.4±4.3% of predialysis on LEV BID versus 65.7 ± 8.8% on LEV daily ( P = 0.045). No seizures were reported during hospital admission in either group. Conclusions: Compared to LEV daily, BID dosing achieved significantly higher levels and a better recovery to predialysis levels. Although limited by small numbers, a similar relationship between postdialysis levels was not detected.
Neurons Over Nephrons
Brinjikji, Waleed , Demchuk, Andrew M. , Murad, M. Hassan , McDonald, Robert J. , Kallmes, David F. , Murad, Mohammad H, Rabinstein, Alejandro A. , McDonald, Jennifer S. , Murad, M Hassan , Demchuk, Andrew M

Mayo Clinic

Stroke | June 6, 2017 | Volume: 48 | Issue: 7 | Pages: 1862-1868

10.1161/strokeaha.117.016771 | PMID 28583996 Get It

Background and Purpose— Because of the perceived risk of contrast-induced acute kidney injury (AKI), many centers require pre-imaging serum creatinine levels, potentially delaying care. We performed a systematic review and meta-analysis evaluating AKI rates in patients with acute ischemic stroke receiving computed tomographic angiography (CTA) and computed tomographic perfusion (CTP). Methods— We searched MEDLINE, EMBASE, and the Web of Science through December 2016 for studies reporting on AKI in patients with acute ischemic stroke receiving CTA/CTP. Using a random-effects model, estimates were pooled across studies. Outcomes of interest were (1) the odds of AKI in patients receiving CTA/CTP versus noncontrast computed tomography, (2) overall rate of AKI and hemodialysis in patients with acute ischemic stroke undergoing CTA/CTP, and (3) the odds of CTA/CTP-associated AKI among patients with and without chronic kidney disease. Results— Fourteen studies were included (6 case–control studies and 8 single-arm studies) with 5727 CTA/CTP and 981 noncontrast computed tomography patients. In case–control studies, AKI was significantly lower among CTA/CTP patients compared with noncontrast computed tomography patients (odds ratio=0.47; 95% confidence interval=0.33–0.68; P <0.01). Adjusting for baseline creatinine, there was no difference in AKI rates between groups (odds ratio=0.34; 95% confidence interval=0.10–1.21). The overall rate of AKI in CTA/CTP patients was 3% (95% confidence interval=2%–4%). The overall rate of hemodialysis in the CTA/CTP group was 0.07% (3 of 4373). There was no difference in AKI among CTA/CTP patients with and without chronic kidney disease (odds ratio=0.63; 95% confidence interval=0.34–1.12). Conclusions— Nonrandomized evidence suggests that CTA/CTP are not associated with statistically significant increase in risk of AKI in patients with stroke, even those with known chronic kidney disease.
Caution Regarding Government-Mandated Shared Decision Making for Patients With Atrial Fibrillation
Coylewright, Megan , Holmes, David R.

Mayo Clinic

Circulation | June 5, 2017 | Volume: 135 | Issue: 23 | Pages: 2211-2213

10.1161/circulationaha.117.026285 | PMID 28584027 Get It

Reply by the Authors of the Original Article: SYNTAX Score and Left Ventricular Reverse Remodeling after Bypass
Reddy, Yogesh N.V. , Alla, Venkata , Kanmanthareddy, Arun , Suri, Rakesh M. , Narayanan, Mahesh Anantha , Nishimura, Rick

Mayo Clinic

The Thoracic and Cardiovascular Surgeon | June 5, 2017 | Volume: 65 | Issue: 06 | Pages: 458-459

10.1055/s-0037-1603623 | PMID 28582789 Get It

Incidental Pulmonary Nodules Reported on CT Abdominal Imaging: Frequency and Factors Affecting Inclusion in the Hospital Discharge Summary
Bates, Ruth , Plooster, Corbin, Croghan, Ivana T. , Schroeder, Darrell R. , Croghan, Ivana, Schroeder, Darrell, McCoy, Christopher, McCoy, Christopher P. , Schroeder, Darrell

Mayo Clinic

Journal of Hospital Medicine | June 5, 2017 | Volume: 12 | Issue: 6 | Pages: 454-457

10.12788/jhm.2757 | PMID 28574537 Get It

Incidental imaging findings require an assessment of risk and clinical relevance, as well as consideration of further evaluation. Incidental findings are common on imaging obtained in the hospital, with pulmonary nodules being among the most frequent findings that may require additional evaluation. We conducted a retrospective study to determine the factors associated with documentation of incidental findings in the hospital discharge summary, using pulmonary nodules reported on abdominal computed tomography (CT) as an example of incidental findings with well‐defined follow‐up guidelines. Between January 1, 2012 and December 31, 2014, 7173 patients underwent in‐patient abdominal CT without concurrent chest CT; of these patients, 62.2% were ≥60 years old, 50.6% were men, and 45.5% were current or former smokers. Incidental pulmonary nodules were reported in 402 patients (5.6%; 95% confidence interval [CI], 5.1%‐6.2%). Based on nodule size, reported size stability, and patients' smoking status, 208 patients (2.9%; 95% CI, 2.5%‐3.3%) required follow‐up surveillance, per the 2005 Fleischner Society guidelines. Of these 208 patients, 48 (23%) received discharge summaries that included documentation of the incidental findings, with 34 summaries including a recommendation for nodule follow‐up and 19 summaries including a time frame for repeat CT. Three factors were positively associated with the inclusion of the pulmonary nodule in the discharge summary: mention of the pulmonary nodule in the summary headings of the radiology report (P ≤ 0.001), radiologist recommendations for further surveillance (P ≤ 0.001), and medical discharging service (P = 0.016). These findings highlight the need for a multidisciplinary systems‐based approach to incidental pulmonary nodule documentation and surveillance.
Does Provider Self‐Reporting of Etiquette Behaviors Improve Patient Experience? A Randomized Controlled Trial
Siddiqui, Zishan K. , Bertram, Amanda , Durkin, Nowella , Kebede, Sosena, Ponor, Lucia, Oduyebo, Ibironke, Allen, Lisa, Qayyum, Rehan , Brotman, Daniel J.

Mayo Clinic

Journal of Hospital Medicine | June 5, 2017 | Volume: 12 | Issue: 6 | Pages: 402-406

10.12788/jhm.2744 | PMID 28574528 Get It

BACKGROUNDThere is a glaring lack of published evidence‐based strategies to improve the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) patient experience scores on the physician domain. Strategies that have been used are resource intensive and difficult to sustain.OBJECTIVEWe hypothesized that prompting providers to assess their own etiquette‐based practices every 2 weeks over the course of 1 year would improve patient experience on the physician domain.DESIGNRandomized controlled trial.SETTING4 acute care hospitals.PARTICIPANTSHospitalists.INTERVENTIONHospitalists were randomized to the study or the control arm. The study arm was prompted every 2 weeks for 12 months to report how frequently they engaged in 7 best‐practice bedside etiquette behaviors. Control arm participants received similarly worded questions on quality improvement behaviors.MEASUREMENTProvider experience scores were calculated from the physician HCAHPS and Press Ganey survey provider items.RESULTSPhysicians reported high rates of etiquette‐based behavior at baseline, and this changed modestly over the study period. Self‐reported etiquette behaviors were not associated with experience scores. The difference in difference analysis of the baseline and postintervention physician experience scores between the intervention arm and the control arm was not statistically significant (P = 0.71).CONCLUSIONIn this 12‐month study, biweekly reflection and reporting of best‐practice bedside etiquette behaviors did not result in significant improvement on physician domain experience scores. It is likely that hospitalists' self‐assessment of their bedside etiquette may not reflect patient perception of these behaviors. Furthermore, hospitalists may be resistant to improvement in this area since they rate themselves highly at baseline.
Impact of perioperative anticoagulation on artificial urinary sphincter device survival
Blackburne, Andrew T. , Linder, Brian J. , Elliott, Daniel S. , Linder, Brian J

Mayo Clinic

Scandinavian Journal of Urology | June 5, 2017 | Volume: 51 | Issue: 4 | Pages: 339-341

10.1080/21681805.2017.1322634 | PMID 28580867 Get It

Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States
Kim, Hyun‐seok , Rotundo, Laura, Yang, Ju Dong , Kim, Donghee , Kothari, Neil , Feurdean, Mirela , Ruhl, Constance E. , Ünalp–Arida, Aynur , Kim, H S , Yang, Ju Dong , Kim, Donghee

Mayo Clinic

Journal of Viral Hepatitis | June 5, 2017 | Volume: 24 | Issue: 11 | Pages: 1052-1066

10.1111/jvh.12735 | PMID 28581638 Get It

Summary Hepatitis B virus ( HBV ) infection in the United States is the most common among Asians followed by non‐Hispanic blacks. However, there have been few studies that describe HBV infection and immunity by racial group. Our study aimed to assess racial/ethnic disparities in the prevalence and awareness of HBV infection and immunity using nationally representative data. In the National Health and Nutrition Examination Survey 2011‐2014, 14 722 persons had HBV serology testing. We estimated the prevalence of HBV infection, past exposure, and immunity by selected characteristics and calculated adjusted odds ratios using survey‐weighted generalized logistic regression. Awareness of infection and vaccination history was also investigated. The overall prevalence of chronic HBV infection, past exposure and vaccine‐induced immunity was 0.34% [95% CI 0.24‐0.43], 4.30% [95% CI 3.80‐4.81], and 24.4% [95% CI 23.4‐25.4], respectively. The prevalence of chronic infection was 2.74% [95% CI 1.72‐3.76] in Asians, 0.64% [95% CI 0.35‐0.92] in non‐Hispanic blacks, and 0.15% [95% CI 0.06‐0.24] in non‐Asian, non‐blacks. Only 26.2% of those with chronic infection were aware of their infection. The prevalence of the past exposure was 21.5% [95% CI 19.3‐23.7] in Asians, 8.92% [95% CI 7.84‐9.99] in non‐Hispanic blacks, 2.05% [95% CI 1.49‐2.63] in non‐Hispanic whites and 4.47% [95% CI 3.25‐5.70] in Hispanics. Prevalence of vaccine‐induced immunity by each race was 34.1% [95% CI : 32.0‐36.2] in Asians, 25.5% [95% CI : 24.0‐27.0] in non‐Hispanic blacks, 24.0% [95% CI : 22.6‐25.4] in non‐Hispanic whites and 22.2% [95% CI : 21.3‐23.3] in Hispanics. There are considerable racial/ethnic disparities in HBV infection, exposure and immunity. More active and sophisticated healthcare policies on HBV management may be warranted.